ISTH 2021 Congress Archives - ISTH Congress Abstracts

Abstract Number: OC 39.2

Nanomedicine Targeting to Activated Neutrophils and Neutrophil-platelet Complexes Provides Effective Thromboprotection

D. Bohinc¹, M. Cruz², J. Alvikas³, N. Masters⁴, S. Haldeman³, K. Bane², K. Medrow², M. Sun², H. Liu⁵, A. Banerjee², E. Lessieur⁶, K. Hageman², A. Gandhi⁷, M. de la Fuente², M. Nieman², T. Kern⁶, K. Neeves⁸, M. Neal⁹, A. Sen Gupta², E.X. Stavrou²
Abstract Number: PB0274

National Survey about Management of Venous Thromboembolism (VTE) Prevention in COVID-19 Patients in Uruguay

A. Pizzarossa¹, M.N. Spangenberg¹, F. Munka¹, B. Borges¹, M. Sosa¹, F. Passarella¹, M. Aguirre¹, E. Falero¹, C. Guillermo¹
Abstract Number: PB1201

National Survey of Hospital–associated Venous Thromboembolism Prevention in NHS England: Findings from the GIRFT Thrombosis Survey

L.N. Roberts¹, M. De Caro², A.-M. Ridgeon³, C. Moroy², T. Briggs^4,3, B.J Hunt⁵, R. Arya¹
Abstract Number: PB1268

Nationwide Children’s Hospital Pediatric and Adult Comprehensive Anticoagulation Program: A Report on its Anticoagulation Management and Clinical Outcomes

V. Rodriguez¹, J. Stanek¹, J. Giver¹, A. Dunn¹, A. Sankar¹, K. Monda¹, J. Canini¹, B. Kerlin¹
Abstract Number: PB0950

Nationwide Screening Programme for Bleeding Disorders Among Adolescent Girls

M. Ross¹, K. Ilves¹.
Abstract Number: PB0749

Native Rotational Thromboelastometry in Chemotherapy Induced Thrombocytopenia

A.-M. Hulshof¹, F. Heubel-Moenen¹, F. Tjahjadi², C. Saelmans², T. van de Berg², E. Beckers¹, T. Hackeng², Y. Henskens¹
Abstract Number: PB0290

Native Rotational Thromboelastometry Observations in Critically Ill COVID-19 Patients

A.-M. Hulshof¹, M. Nagy², F. Tjahjadi², F. Heubel-Moenen¹, T. Hackeng², H. ten Cate², B. van Bussel¹, H. Spronk², Y. Henskens¹
Abstract Number: PB0132

Natural Anticoagulants from Peonies

M. Lyapina¹, M. Kalugina¹
Abstract Number: PB0014

Natural Changes in CHA2DS2-VASc Scores in Newly Diagnosed Non-valvular Atrial Fibrillation Patients with Low Stroke Risk

Q. Chen¹, M.M. Toorop¹, S.C. Cannegieter¹, W.M. Lijfering¹
Abstract Number: PB0391

Natural Fluorescence of Thrombin Substrate Z-Gly-Gly-Arg 7-amino-4-methylcoumarin: Considerations for Wavelength Choice

J. Jackson¹, L. Parunov¹, D. Monteil¹, M. Ovanesov¹
Abstract Number: OC 20.1

NEOCLOT: Management of Catheter-related Venous Thrombosis in Preterm and Term Neonates

C.H. Van Ommen¹, K.A Bergman², M. Boerma¹, A.E. Donker³, M. Gouvernante¹, C.V. Hulzebos², D. Khandour¹, R Knol¹, K. Liem⁴, R.A. van Lingen⁵, M. van de Loo⁶, E Lopriore⁷, M. van der Putten⁸, M. Raets⁸, J.J. Sol⁹, M.H. Suijker¹⁰, D.C. Vijlbrief¹⁰, R Visser⁷, M.M van Weissenbruch⁶, NEOCLOT Study Group
Abstract Number: PB0951

Neurosurgery in a Patient with von Willebrand Disease: A Case-report

J. Cabral¹, C. Calaza¹, M. Calheiros¹, A. Marques¹
Abstract Number: PB1259

Neutralization of the Anticoagulant Effects of Sulodexide by Protamine Sulfate

B. Daravath¹, O. Iqbal¹, D. Hoppensteadt¹, W. Jeske¹, J. Fareed¹
Abstract Number: PB1253

Neutralization of the Oral and Parenteral Anti-Xa Agents by Andexanet Alfa

F. Siddiqui¹, D. Hoppensteadt¹, J. Walenga¹, W. Jeske¹, A. Tafur², E. Ramacciotti¹, J. Fareed¹
Abstract Number: OC 24.2

Neutralizing and Non-neutralizing Anti-FVIII Antibodies in Black and White Hemophilia A Subjects: A Natural History Profile

K.P. Pratt¹, D. Gunasekera¹, P. Vir¹, S. Tan^2,3, G.F. Pierce⁴, C. Olsen¹, S. Butenas⁵, K.G. Mann⁵
Abstract Number: LPB0038

Neutrophil Binding on E-selectin: a Potential Biomarker of Clinical Course and Response to Therapy in Sickle Cell Disease

Y. Man¹, E. Kucukal¹, S. Liu¹, R. An¹, U. Goreke¹, W.J. Wulftange¹, Z. Sekyonda¹, K. Cheng¹, A. Bode^1,2, A. Hill^1,2, K. Monchamp^1,2, J.A. Little³, D. Manwani⁴, E.X. Stavrou^1,5, U.A. Gurkan¹
Abstract Number: OC 15.3

Neutrophil Extracellular Traps in COVID-19 Patients Correlates with Therapy, Disease Severity and Mortality

D. Kassina¹, A. Gur'ev^1,2, A. Martyanov^3,4,5, A. Boldova⁴, M. Stepanyan^6,4, O. An^7,4, S. Tsarenko⁸, F. Ataullakhanov^4,3,6, A. Sveshnikova^6,3,4,7, A. Volkov²
Abstract Number: LPB0037

Neutrophil Extracellular Traps in Thrombosis of Ovine Extracorporeal Membrane Oxygenation Models

Y. Zhang¹, R. Peng¹, S. Gao², B. Ji², Z. Zhou¹
Abstract Number: PB0118

Neutrophils Can Promote Clotting by Secreting Proteins that Activate FXI while NETs Promote Clotting Independently of FXI in vitro

Y. Shi¹, J.S. Gauer¹, S.R. Baker^2,1, H. Philippou¹, S.D. Connell³, R.A.S. Ariëns¹
Abstract Number: PB0119

Neutrophils Promote Tissue Factor-dependent Thrombin Generation in the Absence of Platelets

I.I. Ivanov¹, M.T. Harper¹
Abstract Number: PB1299

New Criteria for Assessing Hemostasis Disorders in Pregnant Women with Chronic Kidney Disease

I. Vasilenko^1,2, I. Nikolskaya³, E. Shestero³, V. Metelin^1,2, D. Kassina¹
Abstract Number: PB0483

New Likely Pathogenic Variants in Three Spanish Patients with Mild Hemophilia A and B: Importance of Genetic Counseling

M. Civeira¹, R. Lahoz-Alonso², R. González-Tarancón², N. Fernández-Mosteirín¹, J.M. Calvo-Villas¹, S. Izquierdo-Alvarez²
Abstract Number: PB0985

New Strategies for Minimization of Surface-induced Platelet Activation

T.H. Nguyen¹, G. Apte¹, L.-Y. Chen¹, A. Lindenbauer¹
Abstract Number: OC 39.3

New strategy to improve the detection of large neutrophil-derived extracellular vesicles in plasma by fluo-sensitive flow cytometry

A. Bonifay¹, S. Robert¹, B. Champagne¹, P.-R. Petit², A. Eugène², C. Chareyre¹, L. Vallier¹, R. Lacroix^2,1, F. Dignat-George^2,1
Abstract Number: PB0036

New Thromboplastin-based Modification of Thromboembolic Ischemic Stroke Model in Rats

I. Ostrova¹, Z. Tsokolaeva^1,2, S. Kalabushev^1,3, I. Ryzhkov¹
Abstract Number: PB0329

Newly Developed Dilute Russell’s Viper Venom Reagents for Lupus Anticoagulant Detection

L. Talon¹, V. Fourneyron¹, M. Tardieu¹, A. Trapani¹, T. Sinegre¹, A. Lebreton^1,2
Abstract Number: PB0381

Newly Developed Ellagic Acid Based APTT Reagent Showed High Lupus Anticoagulant Sensitivity

O. Kumano¹, D. Shimomura², K. Kitano¹, N. Arai¹, T. Matsumoto³.
Abstract Number: PB0359

Next Generation Sequencing in Patients with Bleeding, Thrombotic and Platelet Disorders: A Single Centre Experience

N. Vilalta¹, I. Tirado¹, L. Romero¹, J.A. Millón¹, M. Carrasco¹, M. Corrochano¹, J.C. Souto¹, J. Mateo¹
Abstract Number: OC 55.4

No Difference in Inhibitor Incidence in Previously Untreated Patients (PUPs) with Severe and Moderately Severe Hemophilia A Treated with a Third-generation Recombinant Factor VIII when Compared with Plasma-derived Factor VIII

A.N.L. Prezotti^1,2, D.M.d.C. Rocha¹, M. Renni³, M.H. Cerqueira³, C. Ferreira⁴, I.S.S. Pinto⁵, M.d.R. Roberti⁶, R. Ribeiro⁷, P.R. Villaça⁸, E. Okazaki⁸, M.d.P.S.V. Orletti¹, S. Medina⁹, C. Lorenzato¹⁰, L.O. de Oliveira¹¹, A.L.M. Leite¹¹, C.M.S.P. Pinto¹², S.V. Antunes¹², S.A.L Montalvão⁹, G.G Yamaguti-Hayakawa^2,9, M.C Ozelo^2,9
Abstract Number: PB1172

Non-malignant Portal Vein Thrombi in Patients with Cirrhosis Consist of Intimal Fibrosis with or without a Fibrin-rich Thrombus

E.G. Driever¹, F.A. von Meijenfeldt¹, J. Adelmeijer¹, R.J. de Haas², M.C. van den Heuvel³, C. Nagasami⁴, J.W. Weisel⁴, R.J. Porte⁵, A. Blasi⁶, N. Heaton⁷, S. Gregory⁸, P. Kane⁸, W. Bernal⁷, Y. Zen⁷, T. Lisman^1,5.
Abstract Number: PB0066

Non-thrombogenic Effect Observed with Simulated Concomitant Administration of Anti-hemophilic Factor, Emicizumab and rFVIIa on Thrombin Generation

M.-I. Bravo¹, A. Raventos¹, A. Perez¹, M. Costa¹, T. Willis²
Abstract Number: PB0891

Noonan Syndrome Bleeding Diathesis: Coagulation Factor Deficiencies and/or Platelet Function Disorders?

M. Daniel¹, J.-C. Bordet¹, S. Girard¹, A. Putoux², S. Le Quellec²
Abstract Number: PB0352

Normal Values in Thrombin Generation Parameters in Hemorraghic Diseases

I. Tirado¹, N. Vilalta¹, L. Romero¹, C. Vallvé¹, I. Gich², J.C. Souto¹, J. Mateo¹
Abstract Number: PB1313

Not Yet to Be Born: A Clinical Case of Pseudothrombocytopenia in a Pregnant Woman

A.C.B. Marques¹, A.V.d. Barros¹, JS. Matias¹, M. Manaças¹, F. Carriço¹, A. Miranda¹
Abstract Number: PB0657

Novel Hyperactive FIX Variants and their Potential for Hemophilia B Therapy

A.-K. Urbanowitz¹, P. Milanov¹, P. Quade-Lyssy¹, D. Abriss¹, E. Seifried¹, J. Schüttrumpf², J. Schwäble¹
Abstract Number: PB1306

Novel Point of Care Rapid Coagulation Analyzer for Obstetrics – Quantra (SEER Sonorheometry)

A. Karuppiah¹, B.S. Kodali¹
Abstract Number: OC 40.4

Novel, Point-of-Care Coagulation Test Detects Anticoagulation Resistance Predictive of Thrombotic Events in Pediatric ECMO Patients

G.H. Frydman¹, B.M. Berger¹, V. Kostousov^2,3, K. Bruzdoski^2,3, D. Papageorgiou¹, A. Gokhale^2,3, A.H. Navaei^2,3, L.A. Hensch^2,3, S.R. Hui^2,3, J. Teruya^2,3
Abstract Number: PB0436

NSAIDs prescription use and subsequent risk of upper gastrointestinal bleeding: a time-trend analysis

A. Bedene¹, E.L. van Dorp¹, F.R. Rosendaal¹, A. Dahan¹, W.M. Lijfering¹
Abstract Number: LPB0101

Nucleotides Inhibit Serine Proteases Involved in Blood Clotting and Other Cellular Processes

F. Birkle¹, Y. Wang², N. Collins³, J.H. Morrissey¹